Codexis
CDXS
#8881
Rank
โ‚ฌ0.17 B
Marketcap
1,93ย โ‚ฌ
Share price
-0.45%
Change (1 day)
-20.34%
Change (1 year)

Revenue for Codexis (CDXS)

Revenue in 2026 (TTM): โ‚ฌ66.63 Million

According to Codexis 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ68.4 Million. In 2025 the company made a revenue of โ‚ฌ59.91 Million an increase over the revenue in the year 2024 that were of โ‚ฌ57.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Codexis from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ66.63 M11.21%
2025 โ‚ฌ59.91 M5.07%
2024 โ‚ฌ57.02 M-10.12%
2023 โ‚ฌ63.45 M-50.89%
2022 โ‚ฌ0.12 B39.68%
2021 โ‚ฌ92.49 M64.76%
2020 โ‚ฌ56.14 M-8.13%
2019 โ‚ฌ61.11 M15.37%
2018 โ‚ฌ52.96 M27.04%
2017 โ‚ฌ41.69 M-10.2%
2016 โ‚ฌ46.42 M21.44%
2015 โ‚ฌ38.23 M31.7%
2014 โ‚ฌ29.03 M25.59%
2013 โ‚ฌ23.11 M-65.37%
2012 โ‚ฌ66.75 M-30.01%
2011 โ‚ฌ95.37 M18.45%
2010 โ‚ฌ80.52 M39.15%
2009 โ‚ฌ57.86 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ55.46 B 80,976.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ57.61 B 84,118.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Dupont De Nemours
DD
โ‚ฌ5.37 B 7,761.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Balchem
BCPC
โ‚ฌ0.92 B 1,253.98%๐Ÿ‡บ๐Ÿ‡ธ USA